NCT00035880View on ClinicalTrials.gov

Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

October 31, 1999

Study Completion Date

June 30, 2003

Conditions
Graft Vs Host Disease
Interventions
DRUG

ABX-CBL

Trial Locations (1)

94555

Abgenix, Inc, Fremont

Sponsors

Lead Sponsor

Abgenix
All Listed Sponsors
collaborator

Sangstat Medical Corporation

INDUSTRY

lead

Abgenix

INDUSTRY

NCT00035880 - Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease | Biotech Hunter | Biotech Hunter